Browsed by
Tag: medical

Tips for Navigating Medical Care Without Health Insurance

Tips for Navigating Medical Care Without Health Insurance

Millions of people in the U.S. live without health insurance, a circumstance that can cause people to weigh the need to see a doctor against the cost. Unfortunately, many people will put off or do without medical care because they can’t afford it, a decision that could jeopardize their health.

(Getty Images)

While the Affordable Care Act has boosted the number of Americans with insurance, millions remain uninsured. In 2018, 27.5 million people – more than 8% of the U.S. population – were uninsured, according to the U.S. Census Bureau. Private health insurance covered 67% of Americans. Those without health coverage face the dilemma: Where can I go for medical care without insurance?

The Coverage Gap

In addition to the people who are uninsured, millions are underinsured, according to a survey by the Commonwealth Fund. Among people with health insurance, 29% were underinsured in 2018, compared to 23% in 2014, according to the fund’s Biennial Health Insurance Survey: “People who are ‘underinsured’ have high health plan deductibles and out-of-pocket medical expenses relative to their income and are more likely to struggle paying medical bills or to skip care because of cost.”

The survey found that 41% of underinsured adults reported they delayed needed medical care because of cost. By contrast, 23% of people with adequate insurance coverage said they delayed such treatment. Also, 47% of underinsured adults reported medical bill and debt problems.

Tips for Finding Affordable Medical Care

If you’re uninsured or underinsured, here are eight strategies for finding affordable medical care:

1. Research your eligibility for insurance.

Depending on your situation, you might be eligible to buy individual health insurance coverage from the ACA marketplace or in the individual market, or you might qualify for Medicaid, Medicare or the Children’s Health Insurance Program for your kids, says Kim

Read the rest
Insights on Medical Marijuana Market within the Pharmaceuticals Sector | Increasing Production of Medical Marijuana to Emerge as a Key Driver | Technavio

Insights on Medical Marijuana Market within the Pharmaceuticals Sector | Increasing Production of Medical Marijuana to Emerge as a Key Driver | Technavio

LONDON–(BUSINESS WIRE)–The global medical marijuana market is expected to grow at a CAGR of over 24% during 2020-2024, according to the latest market research report by Technavio. The report provides a detailed analysis on the impact and new opportunities created by the COVID-19 pandemic. The report also helps clients keep up with new product launches in direct & indirect COVID-19 related markets.

Learn more about how COVID-19 is impacting the medical marijuana market – Request a free sample report

The demand for medical marijuana has increased significantly over the years. The growing demand has led many medical marijuana manufacturers to increase production. Besides, many governments worldwide are legalizing marijuana for medical applications, which has further increased demand. For instance, the Government of Manipur, India recently announced its plans to legalize marijuana for medical applications by encouraging start-ups that develop medical marijuana products. Such initiatives are expected to positively influence the growth of the global medical marijuana market during the forecast period.

Medical Marijuana Market: COVID-19 Impact Analysis on Related Markets

Global Legal Cannabis Market 2020-2024

Get FREE Sample Report

Global Cannabis-infused Edible Products Market 2020-2024

Get FREE Sample Report

Global Cannabis Testing Market 2020-2024

Get FREE Sample Report

Medical Marijuana Market: COVID-19 Impact Analysis on Parent Market

The global pharmaceuticals market is the parent market of the medical marijuana market. Within its scope, the pharmaceuticals market covers products and companies engaged in R&D or production of generic drugs, non-generic drugs, and veterinary drugs. Our report on the medical marijuana market offers a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as analysis on several large and small vendors active in the market including Aurora Cannabis, GW Pharmaceuticals, mCig, Medical Marijuana, and United Cannabis.

Technavio’s research report on the medical marijuana market identifies the

Read the rest
Algernon Pharmaceuticals Appoints Dr. Mark Swaim MD, PhD to its Medical and Scientific …

Algernon Pharmaceuticals Appoints Dr. Mark Swaim MD, PhD to its Medical and Scientific …

VANCOUVER, British Columbia, Oct. 09, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that Dr. Mark Swaim, a former practicing physician and researcher has joined the Algernon Medical and Scientific Advisory Board.

Dr. Mark Swaim, MD, PhD graduated from Duke University with honours, where he was an NIH-sponsored Medical Scientist Training Program scholar, and was elected to the Alpha Omega Alpha Honor Medical Society and served as its president. He completed post-graduate training in internal medicine, gastroenterology and hepatology at Duke University Medical Center and post-doctoral research at National Taiwan University in Taipei. Dr. Swaim served on the faculties of Duke University Medical Center, University of Texas MD Anderson Cancer Center and the McGovern Medical School of University of Texas in Houston. He was elected to fellowship in the American College of Physicians. He is editor-in-chief and founder of  BioPub.co a small-cap biotech special situations investing website with a global following.

Update on South Korea COVID Trial

Due to a lack of sufficiently ill patients, which is a direct result of a highly-successful government initiated pandemic mitigation strategy, the Company has decided to close the investigator-led South Korea trial. Instead, the Company will remain focused on its Phase 2b/3 multinational Ifenprodil COVID study, which currently has enrolled more than 75% of its target enrollment.

The Company has projected that the multinational Phase 2b/3 study will be completed in November 2020, with a planned data readout before the end of Q4, 2020.

“I am very pleased that Dr. Swaim has accepted our invitation to join our Advisory Board and we look forward to working closely with him,” said Christopher J. Moreau, CEO of Algernon Pharmaceuticals. “We also look forward to reaching

Read the rest
Paid family and medical leave insurance program

Paid family and medical leave insurance program

Proposition 118 would create a statewide paid family and medical leave program for workers who’ve earned at least $2,500. The program would allow workers to take up to 12 weeks of leave in most cases, and 16 weeks in the event of pregnancy or childbirth complications. Payments would come from a state-run insurance fund. In workplaces with 10 people or more, workers and employers would each contribute to the fund — at a rate of 0.9% of an employee’s wages — but employers in workplaces of nine or fewer people would be exempt from having to contribute to the premium. Companies with their own programs that meet criteria could opt out.

The case for: Paid family and medical leave would allow workers to stay at home longer with their newborns, care for loved ones in need, or simply prioritize their own health. Without paid leave, workers are often under pressure to return to work more quickly or not to take time off at all. Research has shown that paid leave programs expand employment opportunities and contribute positively to the state economy.

The case against: Workers would be forced to pay into a program that they may never need. That may be especially problematic in a recession, as many individuals and families are having a harder time covering their expenses. Many businesses are struggling, too, and Proposition 118 would add another cost during an uncertain time. Depending on how much the program generates, premium rates may be raised from 0.9% to 1.2%. And while the ballot measure allows certain businesses to opt out, doing so may be complicated and expensive.

Ballot question: “Shall there be a change to the Colorado Revised Statutes concerning the creation of a paid family and medical leave program in Colorado, and, in connection

Read the rest